close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,044.57

-0.66%↓

JNJ

243.69

-1%↓

ABBV

232.05

+1.51%↑

NVS

162.63

+0.37%↑

MRK

121.53

+0.86%↑

LLY

1,044.57

-0.66%↓

JNJ

243.69

-1%↓

ABBV

232.05

+1.51%↑

NVS

162.63

+0.37%↑

MRK

121.53

+0.86%↑

LLY

1,044.57

-0.66%↓

JNJ

243.69

-1%↓

ABBV

232.05

+1.51%↑

NVS

162.63

+0.37%↑

MRK

121.53

+0.86%↑

LLY

1,044.57

-0.66%↓

JNJ

243.69

-1%↓

ABBV

232.05

+1.51%↑

NVS

162.63

+0.37%↑

MRK

121.53

+0.86%↑

LLY

1,044.57

-0.66%↓

JNJ

243.69

-1%↓

ABBV

232.05

+1.51%↑

NVS

162.63

+0.37%↑

MRK

121.53

+0.86%↑

Strona główna・Stock List・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Open

SectorHealthcare

28.02 -3.25

Strong Buy

Price update 13 lut 2026, 20:34 UTC

BuySell

Overview

Share price change

24h

Current

Min

28.19

Max

29.34

Key metrics

By Trading Economics

Income

66M

-35M

Sales

70M

71M

Profit margin

-49.028

Employees

143

EBITDA

66M

-34M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+41.42% upside

Dividends

By Dow Jones

Next Earnings

25 lut 2026

Market Stats

By TradingEconomics

Market Cap

670M

2.8B

Previous open

31.27

Previous close

28.02

News Sentiment

By Acuity

33%

67%

89 / 352 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

12 / 13.14 Support & Resistance

VIRIDIAN THERAPEUTICS INC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 lut 2026, 23:57 UTC

Hot Stocks

Stocks to Watch: Applied Materials, Arista, DraftKings, Pinterest

DJ

Read

12 lut 2026, 23:35 UTC

Earnings
Major Market Movers

Arista Networks Surges on AI Networking Demand, Despite Rising Costs

DJ

Read

12 lut 2026, 23:28 UTC

Earnings

Applied Materials Profit Rises on Soaring AI Demand -- Update

DJ

Read

12 lut 2026, 21:47 UTC

Earnings

Vertex Pharmaceuticals Revenue Climbs on Continued Cystic Fibrosis Demand

DJ

Read

13 lut 2026, 00:00 UTC

Market Talk

ANZ Gets a New Bull as Productivity Prospects Improve -- Market Talk

DJ

Read

12 lut 2026, 23:47 UTC

Market Talk

Nikkei May Fall After AI Concerns Drag Stocks on Wall Street -- Market Talk

DJ

Read

12 lut 2026, 23:38 UTC

Market Talk

Gold Steady; Could Undergo Technical Recovery -- Market Talk

DJ

Read

12 lut 2026, 23:33 UTC

Earnings

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- 2nd Update

DJ

Read

12 lut 2026, 23:09 UTC

Market Talk

South32's Hermosa Review Stokes Spending Fears -- Market Talk

DJ

Read

12 lut 2026, 22:55 UTC

Earnings
Hot Stocks

Applied Materials, DraftKings, Airbnb: Earnings in Focus -- WSJ

DJ

Read

12 lut 2026, 22:46 UTC

Market Talk

Northern Star Outlook Needs Project Done On Time, In Budget -- Market Talk

DJ

Read

12 lut 2026, 22:23 UTC

Earnings

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- Update

DJ

Read

12 lut 2026, 22:15 UTC

Earnings

Agnico-Eagle Mines: Gold Production for 2026 and 2027, Expected at 3.3M to 3.5M Ounces Annually, Is Consistent With Previous Guidance, With Offsetting Adjustments Between Mine Sites >AEM.T

DJ

Read

12 lut 2026, 22:15 UTC

Earnings

Agnico-Eagle Mines Raises Dividend to 45c >AEM.T

DJ

Read

12 lut 2026, 22:15 UTC

Earnings

Agnico-Eagle Mines 4Q Rev $3.56B >AEM.T

DJ

Read

12 lut 2026, 22:15 UTC

Earnings

Agnico-Eagle Mines 4Q EPS $3.04 >AEM.T

DJ

Read

12 lut 2026, 22:00 UTC

Earnings

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

DJ

Read

12 lut 2026, 22:00 UTC

Earnings

Agnico-Eagle Mines 4Q Rev $3.56B >AEM

DJ

Read

12 lut 2026, 22:00 UTC

Earnings

Agnico-Eagle Mines 4Q Net $1.52B >AEM

DJ

Read

12 lut 2026, 22:00 UTC

Earnings

Agnico-Eagle Mines 4Q Adj EPS $2.70 >AEM

DJ

Read

12 lut 2026, 22:00 UTC

Earnings

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

DJ

Read

12 lut 2026, 22:00 UTC

Earnings

Agnico-Eagle Mines 4Q EPS $3.04 >AEM

DJ

Read

12 lut 2026, 21:57 UTC

Earnings

XP 4Q Rev BRL4.95B >XP

DJ

Read

12 lut 2026, 21:52 UTC

Earnings

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

DJ

Read

12 lut 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

12 lut 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Read

12 lut 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

12 lut 2026, 21:47 UTC

Earnings

Morningstar 4Q Rev $641M >MORN

DJ

Read

12 lut 2026, 21:39 UTC

Earnings

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

DJ

Read

12 lut 2026, 21:38 UTC

Earnings

Howmet Stock Jumps. Earnings Show Strength For This Sector. -- Barrons.com

DJ

Read

Peer Comparison

Price change

VIRIDIAN THERAPEUTICS INC Forecast

Price Target

By TipRanks

41.42% upside

12 Months Forecast

Average 41.86 USD  41.42%

High 50 USD

Low 29 USD

Based on 10 Wall Street analysts offering 12 month price targets forVIRIDIAN THERAPEUTICS INC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

9

Buy

1

Hold

0

Sell

Based on 10 analysts giving stock ratings to VIRIDIAN THERAPEUTICS INC - Dist in the past 3 months.

Technical Score

By Trading Central

12 / 13.14Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

89 / 352 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,044.57

↓-0.66%

JNJ

Johnson and Johnson

243.69

↓-1%

ABBV

AbbVie Inc

232.05

↑ +1.51%

NVS

Novartis AG

162.63

↑ +0.37%

MRK

Merck & Co Inc.

121.53

↑ +0.86%
help-icon Live chat